Institute for International Research

Main Conference Day Two: Friday, November 3, 2006

Chair's Opening Remarks

Dan Todd
Senior Manager, Reimbursement and Public Policy
AMGEN
Former Special Assistant, Office of the Administrator
CMS

Medical Affairs Perspective on Part D

A New Focus on Performance and Outcomes – The Impact of MMA Part D on Formulary Decision-Making

Mary Walchak,
Principal,
COVANCE MARKET ACCESS SERVICES

Driving Utilization with Medication Therapy Management Programs (MTMP)

Medication Therapy Management Programs (MTMP) Under Part D: Requirements, Opportunities, and Challenges

Jean Paul Gagnon, PhD,
Director of Public Policy,
SANOFIAVENTIS

Changing Regulations and New Programs Require a Best Practices Approach for Claims Validation

Mel Walker,
Senior Director, Life Sciences Strategy,
IMANY

Medicare Part D Strategies for Manufacturers

Jean Paul Gagnon, PhD
Director of Public Policy
SANOFI-AVENTIS

Inside the Beltway Perspective

1:30

HHS Perspective

Abby Block,
Director, Center for Beneficiary Choices,
CMS

OIG Update: Early Implementation Results

Ann Maxwell,
Regional Inspector General for Evaluation and Inspections,
OIG/OEI

Beneficial Collaborations between CMS and Industry

Laurel Lindstrom
Director
HILLCO PARTNERS
Former Special Assistant in the Office of the Administrator at
CMS